4//SEC Filing
NOUGUES MAXIMO F 4
Accession 0001437749-25-022551
CIK 0001401667other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 8:56 PM ET
Size
6.0 KB
Accession
0001437749-25-022551
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-08$3.53/sh−5,587$19,739→ 208,164 total - Sale
Common Stock
2025-07-09$3.54/sh−3,935$13,910→ 204,229 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 12-14-2020
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001758507
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 8:56 PM ET
- Size
- 6.0 KB